Skip to main content
ALCIDION GROUP LIMITED logo

ALCIDION GROUP LIMITED — Investor Relations & Filings

Ticker · ALC ISIN · AU000000ALC6 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 731 across all filing types
Latest filing 2021-03-23 Capital/Financing Update
Country AU Australia
Listing ASX ALC

About ALCIDION GROUP LIMITED

https://www.alcidion.com

Alcidion Group Limited develops and delivers specialized software solutions designed to enhance patient safety and clinical productivity. The company’s core offering, Miya Precision, is an interoperable platform that consolidates data from disparate clinical systems to provide real-time insights, clinical decision support, and predictive analytics. Complementary products include Patientrack, which automates the monitoring of patient vitals and early warning scores, and Smartpage, a secure clinical communication and task management system. These integrated technologies facilitate digital transformation within hospital environments by streamlining workflows and reducing clinical risk. The company focuses on providing healthcare providers with actionable data to improve care delivery and operational efficiency.

Recent filings

Filing Released Lang Actions
East Lancashire Trust to deploy Patientrack and Smartpage 2 pages 126.7KB
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a new contract deal between Alcidion Group Limited and East Lancashire Hospitals NHS Trust for deployment of healthcare software products. It contains no financial statements, no regulatory form references, no voting results, no management changes, no earnings data, and no detailed report content. The document is short (4311 characters) and reads as a business update or capital/contract announcement. This fits best under Capital/Financing Update (CAP) as it relates to a contract signing and business expansion news rather than a financial report or regulatory filing.
2021-03-23 English
Alcidion signs Medications Management contract with NZ DHBs 3 pages 157.4KB
Capital/Financing Update Classification · 95% confidence The document is a press release announcing that Alcidion Group Limited has signed a contract with New Zealand's Te Manawa Taki DHBs for a pilot implementation of an electronic medication management solution. It details the contract value, project scope, and strategic significance but does not contain financial statements, regulatory certifications, or detailed financial results. It is not an annual or interim report, audit report, earnings release, or any form of financial filing. It is an update on a contract signing and business development. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to a new contract and business expansion.
2021-03-01 English
Alcidion FY21 Half Year Report and Appendix 4D 34 pages 2.4MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Alcidion H1 FY2021 Results' and contains detailed financial data for the six-month period ending 31 December 2020, including revenue, gross profit, EBITDA, cash reserves, and contract wins. It includes a letter from the Chair, Managing Director's report, financial review, auditor's independence declaration, directors' declaration, independent auditor's review report, and full financial statements such as profit or loss, financial position, changes in equity, cash flows, and notes. The document is comprehensive and covers a half-year period, which aligns with an Interim / Quarterly Report. It is not merely an announcement or a brief summary but contains substantive financial data and analysis for the half-year period. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2021
2021-02-24 English
Investor Presentation - Half Year Results 9 pages 1.5MB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation Half Year Results - H1 FY2021' and contains detailed financial highlights, profit and loss statements, contract information, and outlook commentary for the half-year period ending in FY2021. It includes revenue figures, EBITDA, contract values, and operational updates typical of an investor presentation. The document length is 9766 characters, which is substantial and contains substantive financial data and analysis for a half-year period. There is no indication that this is a full annual report or a regulatory filing announcement. The content is consistent with a detailed presentation aimed at investors, focusing on financials, strategy, and market position for the half-year period. Therefore, the most appropriate classification is Investor Presentation (IP).
2021-02-24 English
Alcidion Half Year Results and Investor Webcast Notification 1
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 18 February 2021 from Alcidion Group Limited regarding the upcoming release of its half-year financial results for the six-month period ending 31 December 2020 (H1 FY2021). It invites investors to a live webcast and Q&A session on 25 February 2021. The document does not contain any actual financial data or detailed financial statements, but rather serves as a notification of the forthcoming interim results and webcast event. The document length is only 2464 characters, which is quite short and consistent with an announcement rather than a full report. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2021-02-17 English
Q2 FY2021 Business Update and Appendix 4C 8 pages 483.4KB
Interim / Quarterly Report Classification · 95% confidence The document is an Appendix 4C quarterly cash flow report for the three-month period ended 31 December 2020 (Q2 FY2021) released by Alcidion Group Limited. It includes detailed financial data such as cash flows from operating, investing, and financing activities, contract revenue updates, and business highlights for the quarter. The presence of the Appendix 4C form, which is a regulatory quarterly cash flow report required by the Australian Securities Exchange (ASX), indicates this is a quarterly financial report. The document contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not merely an announcement or a certification, and it is longer than 5,000 characters, so it is not a report publication announcement or regulatory filing. Therefore, the correct classification is Interim / Quarterly Report (IR). Q2 2021
2021-01-26 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.